147 related articles for article (PubMed ID: 34718096)
1. Prediction of nitrofurantoin resistance among Enterobacteriaceae and mutational landscape of in vitro selected resistant Escherichia coli.
Khamari B; Adak S; Chanakya PP; Lama M; Peketi ASK; Gurung SA; Chettri S; Kumar P; Bulagonda EP
Res Microbiol; 2022; 173(1-2):103889. PubMed ID: 34718096
[TBL] [Abstract][Full Text] [Related]
2. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.
Vervoort J; Xavier BB; Stewardson A; Coenen S; Godycki-Cwirko M; Adriaenssens N; Kowalczyk A; Lammens C; Harbarth S; Goossens H; Malhotra-Kumar S
Antimicrob Agents Chemother; 2014 Dec; 58(12):7225-33. PubMed ID: 25246406
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology and nitrofurantoin resistance determinants of nitrofurantoin-non-susceptible Escherichia coli isolated from urinary tract infections.
Mottaghizadeh F; Mohajjel Shoja H; Haeili M; Darban-Sarokhalil D
J Glob Antimicrob Resist; 2020 Jun; 21():335-339. PubMed ID: 31627025
[TBL] [Abstract][Full Text] [Related]
4. Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli.
Ho PL; Ng KY; Lo WU; Law PY; Lai EL; Wang Y; Chow KH
Antimicrob Agents Chemother; 2016 Jan; 60(1):537-43. PubMed ID: 26552976
[TBL] [Abstract][Full Text] [Related]
5. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
[TBL] [Abstract][Full Text] [Related]
6. Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates.
Zhang X; Zhang Y; Wang F; Wang C; Chen L; Liu H; Lu H; Wen H; Zhou T
Int J Antimicrob Agents; 2018 Aug; 52(2):226-232. PubMed ID: 29753133
[TBL] [Abstract][Full Text] [Related]
7. Efflux pumps AcrAB and OqxAB contribute to nitrofurantoin resistance in an uropathogenic Klebsiella pneumoniae isolate.
Xu Q; Jiang J; Zhu Z; Xu T; Sheng ZK; Ye M; Xu X; Wang M
Int J Antimicrob Agents; 2019 Aug; 54(2):223-227. PubMed ID: 31200021
[TBL] [Abstract][Full Text] [Related]
8. Exploring the in situ evolution of nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli isolates.
Vallée M; Harding C; Hall J; Aldridge PD; Tan A
J Antimicrob Chemother; 2023 Feb; 78(2):373-379. PubMed ID: 36480295
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antibacterial activity of nitrofurantoin against clinical isolates of E. coli in Japan and evaluation of biological cost of nitrofurantoin resistant strains using a mouse urinary tract infection model.
Nakagawa S; Kurimoto Y; Ezumi M; Nakatani K; Mizunaga S; Yamagishi Y; Mikamo H
J Infect Chemother; 2021 Feb; 27(2):250-255. PubMed ID: 33060044
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in
Sorlozano-Puerto A; Lopez-Machado I; Albertuz-Crespo M; Martinez-Gonzalez LJ; Gutierrez-Fernandez J
Antibiotics (Basel); 2020 Aug; 9(9):. PubMed ID: 32847131
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Genetic Bases of Nitrofurantoin Resistance in Clinical Isolates of Two Successful Multidrug-Resistant Clones of Salmonella enterica Serovar Typhimurium: Pandemic "DT 104" and pUO-StVR2.
García V; Montero I; Bances M; Rodicio R; Rodicio MR
Microb Drug Resist; 2017 Jun; 23(4):405-412. PubMed ID: 27809653
[TBL] [Abstract][Full Text] [Related]
12. Alterations in chromosomal genes
Wan Y; Mills E; Leung RCY; Vieira A; Zhi X; Croucher NJ; Woodford N; Jauneikaite E; Ellington MJ; Sriskandan S
Microb Genom; 2021 Dec; 7(12):. PubMed ID: 34860151
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
14. IS
Wan Y; Sabnis A; Mumin Z; Potterill I; Jauneikaite E; Brown CS; Ellington MJ; Edwards A; Sriskandan S
Microb Genom; 2023 Sep; 9(9):. PubMed ID: 37672334
[TBL] [Abstract][Full Text] [Related]
15. Improving nitrofurantoin resistance prediction in
Dulyayangkul P; Sealey JE; Lee WWY; Satapoomin N; Reding C; Heesom KJ; Williams PB; Avison MB
Antimicrob Agents Chemother; 2024 May; ():e0024224. PubMed ID: 38767379
[TBL] [Abstract][Full Text] [Related]
16. Resistance to nitrofurantoin is an indicator of extensive drug-resistant (XDR)
Khamari B; Kumar P; Pradeep BE
J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33830906
[No Abstract] [Full Text] [Related]
17. Antimicrobial susceptibility of bacteria isolated from urine samples obtained from nursing home residents.
Das R; Perrelli E; Towle V; Van Ness PH; Juthani-Mehta M
Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1116-9. PubMed ID: 19785518
[TBL] [Abstract][Full Text] [Related]
18. Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States.
Mediavilla JR; Patrawalla A; Chen L; Chavda KD; Mathema B; Vinnard C; Dever LL; Kreiswirth BN
mBio; 2016 Aug; 7(4):. PubMed ID: 27578755
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant
Amladi AU; Abirami B; Devi SM; Sudarsanam TD; Kandasamy S; Kekre N; Veeraraghavan B; Sahni RD
Indian J Med Res; 2019 Feb; 149(2):185-191. PubMed ID: 31219082
[TBL] [Abstract][Full Text] [Related]
20. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
